Reports for AA PHARMA INC
Company Name
AA PHARMA INC
Totals |
||
Shortage reports |
372 |
|
Actual shortage: | 25 (7%) | |
Anticipated shortage: | 2 (1%) | |
Avoided shortage: | 6 (2%) | |
Resolved: | 339 (91%) | |
Discontinuation Reports |
58 |
|
To be discontinued: | 1 (2%) | |
Discontinued: | 55 (95%) | |
Reversed: | 2 (3%) | |
Late reports |
29 (7%) |
|
Overdue reports |
11 (39%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
PINAVERIUM | 100MG | TABLET | Resolved | 2021-07-22 | 2021-08-20 | 142861 |
PINAVERIUM | 100MG | TABLET | Resolved | 2023-11-01 | 2023-12-04 | 208859 |
PINAVERIUM | 100MG | TABLET | Actual shortage | 2024-05-24 | 2024-05-24 | 228789 |
AA-RISEDRONATE DR | 35MG | TABLET (DELAYED-RELEASE) | Resolved | 2021-10-29 | 2021-11-19 | 148545 |
AA-RISEDRONATE DR | 35MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-03-18 | 2022-04-06 | 156999 |
AA-RISEDRONATE DR | 35MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-10-14 | 2023-01-06 | 171833 |
AA-RISEDRONATE DR | 35MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-12-02 | 2022-12-23 | 176948 |
AA-RISEDRONATE DR | 35MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-12-13 | 2024-02-22 | 213143 |
AA-RISEDRONATE DR | 35MG | TABLET (DELAYED-RELEASE) | Resolved | 2024-04-04 | 2024-05-30 | 224320 |
AA-THEO LA | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-04-24 | 2021-10-14 | 82343 |
PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-04-29 | 2022-07-23 | 159738 |
AA-LEVOCARB CR | 50MG 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-05-16 | 2017-06-02 | 10406 |
AA-LEVOCARB CR | 50MG 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-09-04 | 2017-10-24 | 20879 |
AA-LEVOCARB CR | 50MG 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-09-26 | 2017-10-24 | 23561 |
AA-LEVOCARB CR | 50MG 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-01-17 | 2018-03-08 | 36301 |
AA-LEVOCARB CR | 50MG 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-05-23 | 2018-08-21 | 50150 |
AA-LEVOCARB CR | 200MG 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-02-11 | 2021-08-03 | 133794 |
AA-LEVOCARB CR | 50MG 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-11-01 | 2024-01-03 | 208870 |
LITHMAX | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-12-07 | 2024-01-20 | 212786 |
LITHMAX | 300MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-03-11 | 2024-05-17 | 221857 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
FLOCTAFENINE | 200MG | TABLET | Discontinued | 2018-12-20 | 2022-01-27 | 70194 |
FLOCTAFENINE | 400MG | TABLET | Discontinued | 2018-12-20 | 2022-01-27 | 70197 |
SULFINPYRAZONE | 200MG | TABLET | Discontinued | 2018-12-20 | 2022-01-27 | 70200 |
TENOXICAM | 20MG | TABLET | Discontinued | 2018-12-20 | 2022-01-27 | 70203 |
TOLBUTAMIDE | 500MG | TABLET | Discontinued | 2018-12-20 | 2022-01-27 | 70206 |
TRIHEXYPHENIDYL | 2MG | TABLET | Reversed | 2018-12-20 | 2019-07-22 | 70209 |
TRIHEXYPHENIDYL | 5MG | TABLET | Reversed | 2018-12-20 | 2019-07-22 | 70212 |
CIMETIDINE | 300MG | TABLET | To be discontinued | 2019-01-02 | 2019-01-02 | 70796 |
TICLOPIDINE | 250MG | TABLET | Discontinued | 2019-04-01 | 2019-04-02 | 80166 |
DIFLUNISAL | 250MG | TABLET | Discontinued | 2020-03-10 | 2020-03-11 | 108364 |
DIFLUNISAL | 500MG | TABLET | Discontinued | 2020-03-10 | 2020-03-11 | 108367 |
ISDN | 5MG | TABLET | Discontinued | 2020-03-10 | 2020-03-11 | 108370 |
ERYTHRO-S | 250MG | TABLET | Discontinued | 2020-07-28 | 2020-07-29 | 121300 |
ERYTHRO-ES | 600MG | TABLET | Discontinued | 2020-08-06 | 2020-08-06 | 121825 |
ORAP | 2MG | TABLET | Discontinued | 2020-08-06 | 2020-08-06 | 121834 |
ORAP | 4MG | TABLET | Discontinued | 2020-08-06 | 2020-08-06 | 121837 |
ERYTHRO-BASE | 250MG | TABLET | Discontinued | 2022-04-01 | 2022-04-02 | 157808 |
PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-23 | 2022-01-27 | 65438 |